There are no “side effects” per se. Most people just enjoy the health benefits of increasing their own nitric oxide. On very rare occasions some may initially have some digestive upset (loose bowels) which typically gets better after a few days.
Some that have herpes may experience an outbreak. Most do not. As a precaution, if this is a concern for you, you might consider taking 1000 mg of Lysine at a different time than taking m3.
M3 is best taken away from meals (at least 20 minutes before or after eating).
Always check with your doctor before adding something new to your daily regime. That being said, thousands of health conscious individuals have added these nutrients into their daily program with no problem. Ask your doctor, “is their any contraindications for me taking these nutrients?”
The recommended dose is two scoops per day. That being said, many with compromised health have doubled (or more) the dosage with excellent results. Again, check with your doctor.
Many people will notice better energy and sleep patterns very soon after taking m3. However, the best results are seen over time. Give it at least 3 to 6 months for specific health challenges you may have.
We use South Korean material which start by fermentation of glucose. There is no pesticides or heavy metals involved. We test for heavy metals for finished product if required. If the product is not of herbal/plant origin, there is no reason to test pesticides/herbicides.
Nitric Oxide has thousands of studies stating its benefits. The eyes are included. Here are what some authorities are saying regarding various optical functions, “NO is an important mediator of homeostatic [health giving, disease preventing] processes in the eye, such as regulation of aqueous humor dynamics [the amount of fluid inside the eyeball], retinal neurotransmission [the role of the retina in sending electrical signals to the brain] and phototransduction [the conversion of light into electrical signal].” – Survey of Opthalmology
NO for Glaucoma
In the News – NicOx and its partner Bausch & Lomb reported positive top-line results from a mid-stage study of their glaucoma drug candidate. B & L has spent $20 million. “These positive results support the strong potential of our nitric oxide-donating platform in the ophthalmology field”